Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation
暂无分享,去创建一个
Jian-yong Li | Yue Xie | S. Qian | C. Qiao | M. Hong | Qian Sun | Wen-Zhong Wu | Si-Si Chen | Lan Cao